HIPK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.845200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.382600E-01
Normal-vs-Stage2
5.431200E-01
Normal-vs-Stage3
1.565570E-02
Normal-vs-Stage4
9.407000E-01
Stage1-vs-Stage2
6.628000E-01
Stage1-vs-Stage3
4.461900E-02
Stage1-vs-Stage4
6.985800E-01
Stage2-vs-Stage3
1.111230E-01
Stage2-vs-Stage4
4.267800E-01
Stage3-vs-Stage4
6.234300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.706600E-01
Normal-vs-AfricanAmerican
5.447800E-01
Normal-vs-Asian
2.489700E-02
Caucasian-vs-AfricanAmerican
6.114000E-02
Caucasian-vs-Asian
4.557400E-03
AfricanAmerican-vs-Asian
7.429600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.269800E-01
Normal-vs-Female
7.533800E-01
Male-vs-Female
6.528600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.799800E-01
Normal-vs-Age(41-60Yrs)
9.340000E-01
Normal-vs-Age(61-80Yrs)
6.403000E-01
Normal-vs-Age(81-100Yrs)
1.195700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.455200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.613000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.775900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.888570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.210500E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.196900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.974200E-01
Normal-vs-Daily Drinker
2.242000E-01
Normal-vs-Weekly Drinker
4.860800E-01
Normal-vs-Occasional Drinker
9.790000E-01
Normal-vs-Social Drinker
7.620600E-01
Non Drinker-vs-Daily Drinker
8.477000E-01
Non Drinker-vs-Weekly Drinker
6.734600E-01
Non Drinker-vs-Occasional Drinker
1.501830E-01
Non Drinker-vs-Social Drinker
8.013800E-02
Daily Drinker-vs-Weekly Drinker
6.161000E-01
Daily Drinker-vs-Occasional Drinker
1.369960E-01
Daily Drinker-vs-Social Drinker
7.282300E-02
Weekly Drinker-vs-Occasional Drinker
3.571600E-01
Weekly Drinker-vs-Social Drinker
1.668810E-01
Occasional Drinker-vs-Social Drinker
5.382600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.493200E-01
Normal-vs-Grade 2
3.223800E-01
Normal-vs-Grade 3
3.973600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.425500E-02
Grade 1-vs-Grade 3
1.344950E-01
Grade 1-vs-Grade 4
3.493200E-01
Grade 2-vs-Grade 3
7.150400E-01
Grade 2-vs-Grade 4
3.223800E-01
Grade 3-vs-Grade 4
3.973600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.016800E-01
Normal-vs-NonDiabetic
6.826600E-01
Diabetic-vs-NonDiabetic
1.613970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.997900E-02
Normal-vs-NoPancreatitis
6.598600E-01
Pancreatitis-vs-NoPancreatitis
4.619600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.119800E-01
Normal-vs-N1
5.400400E-01
N0-vs-N1
2.879000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.156600E-01
Normal-vs-TP53-NonMutant
7.929000E-01
TP53-Mutant-vs-TP53-NonMutant
4.999400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
